INTRODUCING MedGeneRx® HP 30 PRP
MedGeneRx® HP 30 PRP Kit is FDA Cleared and indicated for the rapid preparation of autologous Platelet Rich Plasma (PRP) from a small sample of blood at the patient’s point of care.
SKU: ZG-PRP-HP30
MedGeneRx® HP 30 PRP Kit Components
• 1 – MedGeneRx® HP 30 Vacutainer
• 2 – 10cc Syringes
• 1 – 21g Butterfly Needle
• 1 – 3 inch 19g Spinal Needle
Key Features – 30cc Protocol
• FDA Cleared, Class II Medical Device, 510(k)Device
• Integrated anticoagulant- No ACD-A needed
• Industry leader in three critical areas:
– Reproducible Concentrations from Consistent Platelet Recovery/85+%
– Balanced pH
– 99% removal of RBC’s
• Vacutainer system for simplified blood collection
• Compatible with your existing YES PRP centrifuge
• Single spin 30 cc’s of whole blood
– 5 cc’s high concentration PRP
– 15 cc’s total plasma yield
510(k) equivalence study conducted and the following mean results were achieved:
• Platelet Concentration Factor at 0 hours = 3.8-4.1x baseline
• Platelet Concentration Factor at 1 Hour = 4.1-4.3 x baseline
• Platelet Recovery % at 1 hours = 53%
• RBC at 0 hours- 0.1
• RBC at 4 hours- 0.01
• pH at 0 hours = 7.59
• pH at 4 Hours = 7.69
• Platelet Activation resting at 0 hours= 9.7%
• Platelet Activation stimulated ADP 0 hours = 95.1%
• Platelet Aggregation at 0 hours = 95.1%
• Platelet Aggregation at 4 Hours = 94.8%
• HCT at 0 hours = 0.0 %
• HCT at 4 Hours = 0.0%
• WBC at 0 hours= 0.3
• WBC at 4 hours= 0.3
Recent Platelet Rich Plasma (PRP) Studies and Articles
Increasing Platelet Concentration in Platelet-Rich Plasma Inhibits Anterior Cruciate Ligament Cell Function in Three-Dimensional Culture
Abstract The anterior cruciate ligament (ACL) is a key stabiliz-er of the knee that is prone to injury, especially inyoung, active women. The annual incidence of ACLrupture in the U.S. [...]
Treatment of Tendon and Muscle Using Platelet-Rich Plasma
Abstract Musculoskeletal injuries and impairments result in over 100 million office visits in the United States per year. Tendons and muscle-related issues account for a significant percentage of these visits. [...]
Treatment of Chronic Wounds with Autologous Platelet-Rich-Plasma
Abstract After treatment with platelet-rich plasma, 50% of the wounds had healed, 35.7% had reduced in size and 14.2% were unchanged in terms of area and condition. Recurrencies were not [...]
Treatment of Chronic Elbow Tendinosis With Buffered Platelet-Rich Plasma
Abstract Treatment of patients with chronic elbow tendinosis with buffered platelet-rich plasma reduced pain significantly in this pilot investigation. Further evaluation of this novel treatment is warranted. Finally, platelet-rich plasma [...]
Prevention of Disc Degeneration with Growth Factors
Abstract Clinically, a large number of patients have persistent low back pain attributable to intervertebral disc (IVD) degeneration. After the concept of biologically regenerating the degenerated IVD using growth factor [...]
Platelet-Rich plasma- New clinical application- A pilot study for treatment of jumper’s knee
Abstract This study describes a simple, low-cost, minimally invasive way to apply PRP growth factors to chronic patellar tendinosis; 20 male athletes with a mean history of20.7 months of pain [...]
